Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 1
2011 2
2013 2
2015 1
2016 4
2017 6
2018 3
2019 5
2020 7
2021 8
2022 8
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Randomized trial of TAS-102 for refractory metastatic colorectal cancer.
Mayer RJ, Van Cutsem E, Falcone A, Yoshino T, Garcia-Carbonero R, Mizunuma N, Yamazaki K, Shimada Y, Tabernero J, Komatsu Y, Sobrero A, Boucher E, Peeters M, Tran B, Lenz HJ, Zaniboni A, Hochster H, Cleary JM, Prenen H, Benedetti F, Mizuguchi H, Makris L, Ito M, Ohtsu A; RECOURSE Study Group. Mayer RJ, et al. N Engl J Med. 2015 May 14;372(20):1909-19. doi: 10.1056/NEJMoa1414325. N Engl J Med. 2015. PMID: 25970050 Free article. Clinical Trial.
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study.
Pant S, Schuler M, Iyer G, Witt O, Doi T, Qin S, Tabernero J, Reardon DA, Massard C, Minchom A, Lugowska I, Carranza O, Arnold D, Gutierrez M, Winter H, Stuyckens K, Crow L, Najmi S, Hammond C, Thomas S, Santiago-Walker A, Triantos S, Sweiti H, Loriot Y; RAGNAR Investigators. Pant S, et al. Lancet Oncol. 2023 Aug;24(8):925-935. doi: 10.1016/S1470-2045(23)00275-9. Lancet Oncol. 2023. PMID: 37541273 Clinical Trial.
What Is Your Diagnosis?
Longo F, Zotti A. Longo F, et al. J Am Vet Med Assoc. 2021 Jul 1;259(1):33-36. doi: 10.2460/javma.259.1.33. J Am Vet Med Assoc. 2021. PMID: 34125609 Free article. No abstract available.
Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study.
Oh DY, Algazi A, Capdevila J, Longo F, Miller W Jr, Chun Bing JT, Bonilla CE, Chung HC, Guren TK, Lin CC, Motola-Kuba D, Shah M, Hadoux J, Yao L, Jin F, Norwood K, Lebellec L. Oh DY, et al. Among authors: longo f. Cancer. 2023 Apr 15;129(8):1195-1204. doi: 10.1002/cncr.34657. Epub 2023 Feb 7. Cancer. 2023. PMID: 36748723 Free article. Clinical Trial.
Ramucirumab treatment in hepatocellular carcinoma.
Longo F, Carrato A. Longo F, et al. Chin Clin Oncol. 2020 Dec;9(6):83. doi: 10.21037/cco.2019.12.18. Epub 2020 Jan 8. Chin Clin Oncol. 2020. PMID: 32008334 Free article. No abstract available.
[Panitumumab-induced trichomegaly].
Vañó-Galván S, Longo F, Grillo E, Jaén P. Vañó-Galván S, et al. Among authors: longo f. Med Clin (Barc). 2013 Apr 20;140(8):e15. doi: 10.1016/j.medcli.2013.01.006. Epub 2013 Mar 11. Med Clin (Barc). 2013. PMID: 23490492 Spanish. No abstract available.
SEOM-GECOD clinical guideline for unknown primary cancer (2021).
Losa F, Fernández I, Etxaniz O, Giménez A, Gomila P, Iglesias L, Longo F, Nogales E, Sánchez A, Soler G. Losa F, et al. Among authors: longo f. Clin Transl Oncol. 2022 Apr;24(4):681-692. doi: 10.1007/s12094-022-02806-x. Epub 2022 Mar 23. Clin Transl Oncol. 2022. PMID: 35320504 Free PMC article.
Molecular Heterogeneity of High Grade Colorectal Adenocarcinoma.
Perna C, Navarro A, Ruz-Caracuel I, Caniego-Casas T, Cristóbal E, Leskelä S, Longo F, Caminoa A, Santón A, Ferreiro R, Pizarro D, Palacios-Berraquero ML, Palacios J. Perna C, et al. Among authors: longo f. Cancers (Basel). 2021 Jan 10;13(2):233. doi: 10.3390/cancers13020233. Cancers (Basel). 2021. PMID: 33435234 Free PMC article.
50 results